PITFALLS OF PHARMACOKINETIC DOSAGE GUIDELINES IN RENAL-INSUFFICIENCY

被引:16
作者
TURNHEIM, K
机构
[1] Abteilung für Pharmakokinetik, Pharmakologisches Institut der Universität, Vienna
关键词
PHARMACOTHERAPY; RENAL INSUFFICIENCY; PHARMACOKINETICS; RENAL DRUG ELIMINATION; DRUG MONITORING; DOSAGE GUIDELINES;
D O I
10.1007/BF00315145
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As the renal elimination of most drugs is closely correlated with the endogenous creatinine clearance, it is possible to use this parameter of kidney function to adjust drug dosage in renal failure. However, this simple procedure neglects possible changes in the volume of distribution, plasma protein binding, drug metabolism, intestinal absorption, and pharmacodynamics in renal insufficiency, as well as the occurrence of biologically active drug metabolites. Because of these uncertainties in critical cases the validity of the dosage calculated using the creatinine clearance should be checked by clinical surveillance and measurements of drug blood concentrations. Further, pharmacokinetic dosage guidelines based on the individual creatinine clearance may not be applicable to diuretics and drugs which have markedly differing kinetics of pharmacodynamic effects and blood levels.
引用
收藏
页码:87 / 93
页数:7
相关论文
共 69 条
[11]  
CRAIG RM, 1983, J LAB CLIN MED, V101, P496
[12]  
CRAIG WA, 1985, ANTIBIOTICS LABORATO, P515
[13]  
DANHOF M, 1984, J PHARMACOL EXP THER, V230, P627
[14]  
DETTLI L, 1970, POSTGRAD MED J, V46, P32
[15]  
DETTLI L, 1976, Clinical Pharmacokinetics, V1, P126, DOI 10.2165/00003088-197601020-00004
[16]  
DETTLI L, 1971, ACTA PHARMACOL TOX, V29, P211
[17]  
DETTLI L, 1988, KLINISCH PHARMAKOLOG, P138
[18]  
DETTLI L, 1990, ARZNEIMITTELKOMPENDI, P309
[19]  
DETTLI L, 1990, ARNEIMITTEL KOMPENDI, P331
[20]   ACTIVE DRUG METABOLITES AND RENAL-FAILURE [J].
DRAYER, DE .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (04) :486-489